Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis (2024) Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau AR, Li YN, Györfi AH, et al. Journal article Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events (2024) Nikolopoulos D, Loukogiannaki C, Sentis G, Garantziotis P, Manolakou T, Kapsala N, Nikoloudaki M, et al. Journal article EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update (2024) Gossec L, Kerschbaumer A, Ferreira RJ, Aletaha D, Baraliakos X, Bertheussen H, Boehncke WH, et al. Journal article Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery (2024) Lyu P, Wen J, Zhang W, Liu N, Stolzer I, Gießl A, Jia Y, et al. Journal article Bona fide dendritic cells are pivotal precursors for osteoclasts. (2024) Puchner A, Simader E, Saferding V, Hofmann M, Kieler M, Brunner J, Pfeifle R, et al. Journal article 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice (2024) Mandl P, D'Agostino MA, Navarro-Compán V, Geßl I, Sakellariou G, Abhishek A, Becce F, et al. Journal article Erosive hand osteoarthritis and sarcopenia: data from Osteoarthritis Initiative cohort (2024) Moradi K, Kwee RM, Mohajer B, Guermazi A, Roemer FW, Ibad HA, Haugen IK, et al. Journal article CHRONIC TENOSYNOVITIS IS ASSOCIATED WITH LOSS OF GRIP STRENGTH IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS (OP0069) (2023) Bayat S, Coppers B, Kleyer A, Godonou ET, Valor L, Simon D, Fagni F, et al. Journal article POS0156 BONE DENSITY, MICROSTRUCTURE AND BIOMECHANICS OVER A 7-YEAR OBSERVATION PERIOD IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS - INFLUENCE OF AUTOIMMUNITY, DISEASE ACTIVITY AND BIOLOGICAL DMARD TREATMENT (2023) Kemenes S, Tascilar K, Kleyer A, Minopoulou I, Fagni F, Zekovic A, Isnardi CA, et al. Journal article Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells (2023) Meyer A, Sienes RE, Nijim W, Zanotti B, Umar S, Volin MV, Van Raemdonck K, et al. Journal article